Transdiagnostic metacognitive therapy: Metacognitive therapy focuses on metacognitions.
Disorder-specific cognitive-behavioral therapy: Cognitive-behavioral therapy focuses on cognitions and/or behaviors.
Study summary
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age 18 years or older,
* A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
* No change in dose during the last six weeks if on pharmacological treatment, and
* Ability to read and speak Swedish.
Exclusion Criteria:
* A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
* Acute suicide risk, or
* Concurrent psychological treatment.
Primary outcome measure(s)
Qualitative interview data — Up to 13 weeks Participant responses based on questions posed in an interview
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
